BEAT THE BITE
Precision analysis for definitive answers
Longer, hotter summers in the Northeastern United States have allowed certain populations of disease-carrying ticks and insects to flourish and non-native tick and insect species to migrate north. Their arrival has introduced new vector-borne illnesses into these regions. Knowing which illnesses to test for is integral to proper diagnosis.
In the Northeastern U.S., ticks pose the biggest threat to their human neighbors. Increasing in prevalence each year, Lyme disease, which is caused by the black-legged tick (Ixodes scapularis) is the most common vector-borne illness in the region. Appearances of rarer illness, such as Powassan virus disease and babesiosis (which are also carried by the black-legged tick), have similar initial symptom presentation and can pose a complicated question for physicians attempting to ascertain which illness is affecting their patients. Lone star ticks, or Amblyomma americanum, which are a vector for ehrlichiosis and alpha-gal syndrome, have also begun invading southern parts of this region and in some areas have become the predominant species.
According to data from the Centers for Disease Control and Prevention, cases of mosquito-borne disease in the Northeast United States are increasing. Our map highlights cases of mosquito-borne illness reported in 2004, 2011, and 2018.
The Centers for Disease Control and Prevention reports that across the Northeast United States, cases of tick-borne illness have risen substantially. Cases of tick-borne disease reported in 2004, 2011, and 2018 are demonstrated.
250%-350% increase in Lyme disease prevalence in Northeastern and North Central U.S. between 2016 and 20171
For individuals suspected of having vector-borne infectious disease, early diagnosis and treatment are critical to prevent further harm. Mayo Clinic Laboratories’ arsenal of vector-borne disease testing includes serological and molecular evaluations for common and rare illnesses most prevalent in the Northeastern U.S. Not only do we offer testing for individual disease states, such as a newly released Powassan virus test, but comprehensive panels that evaluate for a number of vector-borne conditions that present with similar symptoms.
TESTING AVAILABLE FOR